‘Pharma resistance’ to battle superbugs

  24 September 2020

A group of pharmaceutical ­giants, biotech companies, industry peak bodies and the CSIRO have banded together to form an alliance to combat the “market failure” that inhibits the development of novel antibiotics to fight superbugs.

The Australian Antimicrobial Resistance Network — known as AAMRNet — will work to secure reforms aimed at incentivising antibiotic research and development in the face of an escalating crisis in which modern medicine is running out of ­options to treat drug-resistant infections.

Further reading: The Australian
Author(s): Natasha Robinson
Healthy Patients   Smart Innovations  


Unrestricted financial support kindly provided by

Antimicrobial Resistance Fighter Coalition

Technology Database

Display your AMR Technology, Product and Service


Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.


Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!